July 8, 2008: NOXXON Pharma announces appointment of Lawrence E. Posner to its Board of Directors
June 11, 2008: NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company NOXXON Pharma AG schließt Kooperationsvertrag mit Eli Lilly and Company über die Entwicklung von Spiegelmeren® zur Migränebehandlung
